PPIO-008
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PPIO-008, covering 2024-07-17 to 2024-07-17. Get the full timeline:
Most recent: Clinical Trial Update: PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY [Phase 2]